Indian industry expresses anguish over slow pace of ASEAN FTA renegotiation
By Shailesh Yadav
New Delhi [India], June 24 (ANI): Indian industry is growing increasingly frustrated with the extremely slow progress in renegotiating the ASEAN Free Trade Agreement. Government sources reveal that nine rounds of talks since November 2019 have failed to address fundamental concerns about the lopsided nature of the original deal.
Government sources said the sluggish pace of negotiations, originally scheduled to conclude by 2025, has amplified industry anguish over what many consider an unfavourable trade arrangement that has significantly disadvantaged Indian manufacturers and exporters.
'We are reflecting the anguish of Indian industry as the industry is suffering,' a senior government source said. 'The progress in FTA negotiations has been very slow, and this is causing serious concern across various sectors.'
The renegotiation efforts have revealed several structural problems with the original ASEAN FTA that have created lasting disadvantages for Indian industry. Most notably, India opened 71 per cent of its tariff lines under the agreement, while key ASEAN partners offered far less reciprocal access--Indonesia opened only 41 per cent, Vietnam 66.5 per cent, and Thailand 67 per cent.
The prolonged renegotiation process has left Indian industry in a state of uncertainty, with many sectors continuing to face unfair competition while waiting for more balanced terms. The government's acknowledgement of industry anguish signals a commitment to addressing these long-standing grievances, but the slow pace of talks with ASEAN partners suggests that relief may still be some time away.
This asymmetry has raised questions about the original negotiation strategy, particularly given that India had a lower per capita income compared to several ASEAN nations when the deal was signed.
The consequences of these imbalances have become starkly apparent over the 15-year lifespan of the agreement. While India's exports to ASEAN doubled during this period, the trade deficit has ballooned by a staggering $86 billion as imports from the ASEAN bloc tripled, creating an unsustainable trade relationship.
India is now seeking fairer terms in the renegotiation, citing the rising trade deficit, limited export gains, and uneven tariff cuts that have consistently favoured ASEAN partners over Indian exporters.
A major area of concern has been the routing of Chinese goods through ASEAN countries, which has undermined the intended benefits of the FTA for Indian industry. Government sources indicated that concerns are mounting over this practice, along with non-tariff barriers that continue to impede Indian exports to ASEAN markets.
The government has been forced to take corrective measures, including imposing anti-dumping duties for the first time and implementing safeguard duties on 12 per cent of relevant imports to protect the domestic industry from unfair competition.
The steel sector has been particularly affected, with subsidised goods from third countries being dumped in the Indian market until anti-dumping measures were implemented. The government has also cracked down on steel import dumping through safeguard duties, highlighting that the original FTA lacked crucial provisions like a 'melt-and-pour' clause that could have prevented such practices. (ANI)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
an hour ago
- Mint
Novo Nordisk preparing to launch weight-loss drug Wegovy in India
Danish drugmaker Novo Nordisk is betting on its insulin leadership in India to dominate the country's $25-billion anti-obesity drug market with the imminent launch of its weight-loss therapy, a top company official said. Novo Nordisk is preparing to launch Wegovy in India, where millions of people are battling obesity and demand for the weight-loss drug is expected to be massive. The drug will be launched in several dosage strengths at accessible price-points. 'We are launching with full preparation and we are launching with a big bang to make it happen in India," Vikrant Shrotriya, managing director of Novo Nordisk India, told Mint in an interview. Also read: Ozempic, a patent challenge, and $25 bn race for India's weight-loss drug market Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply and believes that its position as a market leader for insulin products—used to treat and manage diabetes—in the country could give it an edge, Shrotriya said, adding that the company is gunning for a strong market share in the growing Indian anti-obesity market. Novo Nordisk, which shot to popularity through its weight-loss drugs Ozempic and Wegovy, is late to the Indian market. The company launched Ozempic in the US in 2018 and Wegovy in 2021. It lost the first-mover advantage to competitor Eli Lilly, which launched its weight-loss drug Mounjaro (Tirzepatide) in the country in March 2025. It is also staring at a loss of patent protection for Semaglutide—the compound in drugs Ozempic and Wegovy, in India in March 2026. The patent expiration will trigger a rush of generic copies from Indian companies. The company faced several supply constraints over the past few years as demand for its weight-loss drugs shot up globally. 'It was an unprecedented demand after the launch of the products," said Shrotriya, adding that the company has worked on strengthening its supply chain through investments in manufacturing capabilities across the world to plug the gaps. The company will launch Wegovy in India in five dosing strengths, as a pen-filled device, for ease of use. Novo Nordisk already has an oral form of Semaglutide, Rybelsus, in India from 2022. Rybelsus has clocked sales over ₹400 crore in India by March 2025, according to pharma data agency IQVIA. While Shrotriya declined to share the pricing for Wegovy, he said that it would have an 'India-specific" pricing strategy to boost accessibility. Also read: Sun Pharma names Kirti Ganorkar as new managing director, Dilip Shanghvi to continue as chairman Competitor Eli Lilly's drug Mounjaro, sold as a once-a-week vial injection, is priced at ₹17,500 per month. Insulin edge Shrotriya said that the company's leadership in India's insulin market will give it an edge in the anti-obesity segment as well. Novo Nordisk holds the lion's share of India's insulin market, accounting for over 50% of the market. Two of its brands, Mixtard and Ryzodeg, are among the top-selling insulin brands in India. According to pharma intelligence and B2B platform Pharmarack, India's insulin market was valued at ₹4,404 crore in April 2025. 'One out of two patients on insulin depend on us, despite having so many generic players…I think that partnership along with the doctors is something which is very close to our hearts. And that goes a long way to establish ourselves also in this new therapy area, which is obesity. So needless to say, that edge will also play a little bit to an advantage and strength," Shrotriya said. Launching ahead of the patent expiry in March 2026 will also give it an advantage. Semaglutide, the compound in Wegovy is a peptide, like insulin. 'Overall, the response to the market has been very, very good, for our insulin. And we hope to continue the same response in terms of our semaglutide even in the post-patent period," said Shrotriya. Semaglutide and Tirzepatide, which is sold by Eli Lilly under brand name Mounjaro, are GLP-1 (glucagon-like peptide-1) drugs used to treat obesity and type-2 diabetes. Earlier this year, Novo Nordisk said it would phase out pen-filled versions of its top-selling insulin brand Mixtard, which clocks ₹800 crore in annual sales. However, it will continue to sell them in vial form. Shrotriya said that the insulin market would continue to remain a focus for Novo Nordisk. 'We will continue to be a very strong player in the diabetes space with our insulin," he said. Competition in India India has a large obesity burden, with 254 million people with generalized obesity and 351 million people with abdominal obesity, according to a 2023 Indian Council of Medical Research–India Diabetes (ICMR-INDIAB) study. 'India is an unaddressed market, and will possibly be one of the countries with the highest number of patients globally…although it will take time," Shrikant Akolkar, vice-president and head of pharmaceutical research at brokerage Nuvama, told Mint. Also read: Zydus buys Agenus' biologics plants in US for $125 mn, licenses cancer therapy According to a research note by Nuvama, the Indian weight loss market is worth $25 billion and could double in size by 2033. With Novo Nordisk's drug compound Semaglutide set to lose its patent protection in the country in March 2026, several Indian players, including Dr. Reddy's, Sun Pharma, Cipla, Natco and Zydus Lifesciences are gearing up to launch cheaper generic copies of the weight-loss drug. 'The loss of patent could be a challenge for Novo Nordisk as the Indian generics will have the same active ingredient (Semaglutide). If you see global data, patients do not continue on this medicine for long, therefore if generic alternatives are available, people may look at Indian alternatives," Akolkar said. Plus, Eli Lilly's Mounjaro has already gained ground, with ₹23.94 crore in sales in just three months of launch, according to data from Pharmarack. There's a limited window for both Eli Lilly and Novo Nordisk to make money in the Indian anti-obesity market, before competitive generic alternatives enter the space, Akolkar added. Novo Nordisk's reach with doctors will give it an edge, said Akolkar. 'Novo Nordisk, through their oral drug, for the past 3-4 years of groundwork, has laid a good foundation for patient awareness and reach to the doctors. They will possibly have a very good reach and may have to convert that reach from oral to injections as a low-hanging growth opportunity for them," he said.
Mint
an hour ago
- Mint
India preps oil Plan B; Iran hits US bases in Qatar, Iraq
India has prepared a 'Plan B' for oil imports that includes leveraging existing sources of supplies to ensure energy security, two persons informed about the matter said, even as Iran launched missiles at US bases in Qatar and Iraq late on Monday. While the Indian government has been working on its plan since Israel first struck Iran on 13 June, the attack on US bases threatens to draw the US deeper into the West Asia conflict. In the past, Iran has threatened US forces at Al Udeid Air Base, which hosts the forward headquarters of the US military's Central Command. India's Plan B for crude oil will be activated to tide over any exigencies in the event of Iran closing the Strait of Hormuz. To be sure, this vital choke point has remained open even during the years-long Iran-Iraq war in the 1980s. The move comes amid fears of the conflict intensifying, with the US hinting at a regime change in Tehran. Economists expect the crisis to be short-lived and the impact on the economy temporary, but fear investor sentiment may suffer during the crisis. 'India sources crude oil from about 39 countries. This bolsters our position of having multiple sources of oil supply even in the worst-case scenario of a closure of the Strait of Hormuz, which has never happened even during the Iran-Iraq war,' one of the two people cited above said on the condition of anonymity. 'We have 75 days of crude oil reserve including the inventory, also comprising products held by oil marketing companies,' the person added. Out of the 5.5 million barrels of crude oil that India consumes daily, about 1.5-2 million barrels transit the Strait of Hormuz. At the time of writing the story, the August contract of Brent on the Intercontinental Exchange was trading at $77.88 per barrel, higher by 1.38% from its previous close. Similarly, the August contract of West Texas Intermediate on the NYMEX rose 1.23% to $74.75 per barrel. Queries sent to the Union petroleum ministry remained unanswered. The war in West Asia showed no signs of letting up on Monday, as bombs and missiles rained down in Israel and Iran. However, Iran is yet to act on its threat of closing the Strait of Hormuz, a development that could block a fifth of the world's oil cargoes and send oil prices into a spiral. Rahul Kalantri, vice president for commodities at Mehta Equities said: "Oil prices extended gains for a third straight week amid rising geopolitical tensions and a sharper-than-expected drawdown in US inventories. The ongoing hostilities between Israel and Iran have heightened supply concerns across West Asia, a region critical to global oil exports." On Monday, stock market investors took the West Asia pounding in their stride, with benchmarks recouping much of their intra-day losses. The Sensex tumbled over 900 points during the day, but recovered to close with a loss of 511.38 points or 0.62% at 81,896.79. The Nifty dropped 140.50 points or 0.56% to 24,971.90. Experts and sector stakeholders said the market is watching how Iran responds to attacks on its nuclear facilities. The disruption to trade over the Strait of Hormuz may be transitory as any prolonged uncertainty here can hurt Asian nations more than the West, said Rumki Majumdar, an economist at Deloitte India. 'If one considers the million barrels per day of crude oil and condensate transported through this straight, around 60% was traded to Asia, with China accounting for 30% alone in 2024. The exposure to US and EU is less than 10%,' said Majumdar. 'We believe the disruption will be temporary, leading to a temporary spike in global oil prices, and is expected to subside thereafter. The US will also increase its supply from its shore to meet the demand gap. India is probably cushioned enough to manage the temporary price spike through its reserves, so we believe that rising oil prices may not have an impact on India's current account deficit as much,' added Majumdar. 'However, investor sentiment can be more sensitive to geopolitical tensions and in periods of uncertainty, capital tends to flow out of emerging markets. A depreciation in the domestic currency can in turn make energy imports costlier even if dollar price of oil stays rangebound. This can put pressure on current account deficit and retail price inflation,' said Majumdar. Meanwhile, shipping rates have taken collateral damage from the unfolding conflict. Anil Devli, chief executive of the Indian National Shipowners' Association (INSA), said spot freight rates had increased by 150% since the start of the Israel-Iran war. 'Experts and analysts note that a complete closure is unlikely due to the severe economic and strategic risks for Iran itself, though the threat has already heightened tensions and could lead to increased harassment of shipping in the area," Devli added. With Iran threatening to block the Strait, freight rates and premiums may increase further, increasing the landed cost of key supplies such as oil, industry executives and government officials said. If the Strait of Hormuz is closed, both oil prices and tanker and vessel rates on the route are expected to surge significantly. Shippers also fear the war cover provided to vessels operating in the region may be withdrawn if the Israel-Iran conflict escalates further. Daily freight rates of tankers and vessels from West Asia to Japan and South Korea have increased to $50,000 (per vessel) from $20,000 about 10 days ago. The Reserve Bank of India (RBI) has already frontloaded its rate cuts with a 50 basis points reduction in repo rate at the last monetary policy committee meeting. At the next monetary policy review in August, the central bank will have more information on monsoon showers, food prices and the West Asia situation, she explained. 'Unless there is a full-blown war or heightened global tensions leading to spike in inflation, we expect the rates to remain steady,' Majumdar of Deloitte added. UBS said in a research note on Monday that in its base case scenario, it does not expect the escalation in West Asia conflict will lead to a prolonged disruption to oil supplies in a way which could imperil global growth or cause significant challenges for central banks. India's ₹ 1.68 trillion fertilizer subsidy bill for FY26 also faces the prospect of swelling as natural gas price, which tends to follow crude oil price, and shipping cost tend to go up during periods of geopolitical tension. Around 100,000 tonnes of basmati rice destined for Iran are stranded at Indian ports due to the conflict, All India Rice Exporters Association said on Monday. According to the Iranian state media, the Iranian parliament has already voted to block the Hormuz Strait in retaliation. However, the proposal needs the approval of the country's Supreme National Security Council. Iran currently produces about 3.3 million barrels per day (mbd) of crude oil, exporting 1.8-2.0 mbd. While Iranian oil facilities have reportedly been hit, the extent of damage remains unclear. However, the larger risk lies in a broader regional conflict that could pull in other major oil producers in the Gulf. However, any move to block the strait may put significant cost pressures on India, even though it no longer buys oil directly from Iran due to US sanctions. Crude supplies from Iraq, Saudi Arabia, Kuwait, and the United Arab Emirates, all routed via the Strait of Hormuz, account for around 36% of India's total imports. About 60% of its natural gas imports also cross this critical passage. Union petroleum minister Hardeep Singh Puri on Sunday posted on X that India has diversified its supplies in the past few years, and a large volume of its supplies does not come through the Strait of Hormuz. On 13 June, as prices surged after Israel's attacks on Iran, Puri held a review meeting and tweeted that India has adequate energy supplies for the coming months. "Given the geopolitical tensions in the past few years, the Indian government and oil marketing companies have diversified their sources of oil across several countries. And OMCs usually have stocks of more than three months. Such initiatives may help minimize impact on product supplies in the near term," said Gaurav Moda, partner and leader for energy at EY-Parthenon India. An industry executive on condition of anonymity said that prices usually surge significantly in two phases—first, on anticipation of supply disruption and later when disruption is actually witnessed in physical supplies. "For now the surge post anticipation of disruption has by and large taken place and that has been factored in. Now if the strait is actually blocked and supplies get halted, that is when we may see a major rippling effect in prices," the executive said. Oil marketing companies (OMC), would also feel the pinch of high oil prices, while for the exploration and production companies it would bear a positive impact due to higher prices, experts said. Noting that oil prices are up 21-25% since May-end, a report by Kotak Institutional Equities said that the strait of Hormuz is "too critical to be disrupted for long". "Short-term disruptions can lead to further price spikes. Unless the conflict worsens (and impacts the wider ME region), we do not see much impact on demand or supplies. Oil prices would likely trace back if the conflict ends soon. For India, higher oil/gas prices are negative. But for upstream PSUs, these are positive. For OMCs, while higher oil prices are negative, retail price cuts are now on the back-burner," it said. It said that when oil prices were declining and were around $60 per barrel, OMCs were witnessing high margins and there was an expectation of retail price cuts "With geopolitical worries rising, retail price cuts are unlikely soon. If retail prices were cut, a reversal would have been difficult. But if the conflict eases soon, margins may further rise. While OMCs' near-term earnings will remain strong (despite the oil price spike), our key concerns remain on the lack of pricing power and large capex," said the Kotak report. Some of India's exports to Iran are vital for the West Asian nation. India supplies affordable, life-saving medicines to Iran. Because of international restrictions, Iran struggles to get western medicines. This makes them highly dependent on India for common generic drugs, as well as special medicines for serious illnesses like cancer. India also sends raw materials for making drugs, a pharma company executive said, requesting anonymity. India's pharmaceutical exports to Iran crossed $28 million in FY25. Subhash Narayan and Priyanka Sharma contributed to this story.
Mint
an hour ago
- Mint
Stocks to trade today: Trade Brains Portal recommends two stocks for 24 June
Stock market today: The Indian stock market opened sharply lower on Monday, 23 June, as the Sensex plunged over 900 points and the Nifty 50 slipped below 24,850 amid a broad-based selloff triggered by weak global cues. The Sensex opened at 81,704.07, down from its previous close of 82,408.17, and hit an intraday low of 81,476.76, losing more than 900 points, or over 1%. The Nifty 50 opened at 24,939.75 versus Friday's close of 25,112.40, and fell over 1% to touch an intraday low of 24,824.85. However, both indices managed to recoup part of the losses as the session progressed. The Sensex closed 511 points, or 0.62%, lower at 81,896.79, while the Nifty 50 settled at 24,971.90, down 141 points, or 0.56%. Read this | Inside India's SME IPO boom—and why it's getting riskier Against this backdrop, Trade Brains Portal has picked two stocks—one from the financial services sector and another from the metals and mining sector. Stocks to trade today, recommended by Trade Brains Portal for 24 June: Finolex Cables Ltd Current price: ₹ 939 Target price: ₹ 1,150 in 16-24 Months Stop-loss: ₹ 830 Why is Finolex Cables recommended: Finolex Cables Ltd, established in 1958, is one of India's most diversified and leading manufacturers of electrical and telecommunication cables. Responding to evolving market demands, the company has expanded into the fast-moving electrical goods (FMEG) segment, positioning itself as a one-stop provider of electrical solutions. Its broad product portfolio now includes wires and cables, fans, water heaters, switches, switchgear, room heaters, irons, lighting, conduits and fittings, and smart home solutions. The cables and wires range covers power, speaker, LAN, telephone, agricultural, and residential applications. The company delivered a strong financial performance in FY25. Revenue rose 14% year-on-year to ₹1,595 crore in Q4 FY25 from ₹1,401 crore in Q4 FY24. For the full year, revenue grew 6% to ₹5,319 crore from ₹5,014 crore in FY24. Profit after tax in Q4 FY25 increased to ₹192 crore from ₹186 crore a year earlier. For the full year, net profit rose 7.5% to ₹701 crore from ₹652 crore. The company managed commodity price volatility through dynamic pricing strategies. Looking ahead, Finolex plans a capex of ₹104 crore in FY26, along with ₹40–50 crore in maintenance capex. It is also developing new manufacturing plants to support its next phase of growth. The company commissioned its e-beam project in January 2025 and has since launched two new product lines: its most premium wire targeted at the construction segment, and solar cables launched in February 2025. At full capacity, management expects these two product lines to contribute ₹500–600 crore in annual revenue, with more additions planned to strengthen this stream. The outlook for the Indian wire and cable industry remains strong. The market is projected to grow from $21.22 billion in 2025 to $32.85 billion by 2030, at a compound annual growth rate (CAGR) of 9.14% over the forecast period. Read this | How Vedanta's debt burden turned Hindustan Zinc into a net-debt company Risk factors: The company encounters fierce competition from both organized players like Polycab India, KEI Industries, RR Kabel, V-Guard Industries, etc., as well as from unorganized players in the industry. It is also exposed to raw material risk, as fluctuations in the prices of raw materials like copper, aluminium, and fibre optics may significantly influence the company's input costs. Container Corp. Of India Ltd Current price: ₹ 735 Target price: ₹895 in 16-24 Months Stop-loss: ₹ 655 Why is Container Corp. Of India recommended: Incorporated in 1988, Container Corp. Of India (Concor) is a 'Navratna" public sector enterprise under the Ministry of Railways and remains the market leader in its space. It operates 66 terminals across India, including 4 pure EXIM terminals, 35 combined container terminals, 24 domestic terminals, and 3 strategic tie-ups. The company's business is broadly divided into EXIM and domestic segments, and it operates across three verticals: carrier, terminal operator, and warehouse operator. Its extensive asset base includes 130 LNG trucks, 107 reach stackers, five gantry cranes, 29 forklifts, 24 shunting engines, 17,967 container wagons, and 53,187 containers. In FY25, operating revenue rose 2.7% year-on-year to ₹8,887 crore. Ebitda grew 10% to ₹2,330 crore, resulting in a healthy Ebitda margin of 25%. Profit after tax increased 3.5% year-on-year to ₹1,292 crore. The EXIM segment posted 7% growth, while the domestic business expanded 12% year-on-year. Concor's market share now stands at 55.2% in the EXIM segment and 57.6% in the domestic segment. For the first time, the company surpassed the 5 million TEU mark, handling a record 5.09 million TEUs in FY25, with total throughput growth of around 8% during the year. For FY26, the Board has approved a capital expenditure plan of ₹860 crore, primarily allocated toward terminal development, container acquisition, and IT infrastructure. The company has set a long-term goal to scale up to 100 terminals, over 500 rakes, and 70,000 containers by FY28. Management forecasts domestic volume growth of 20% in FY26, while EXIM growth is expected to reach 10%. The company is actively collaborating with Indian Railways and the Dedicated Freight Corridor (DFC) to secure land for future terminal expansion. Also read | Sunteck Realty readies recipe for a strong FY26 even as shares await a rebound Risk factors: EXIM shipments account for over 78% of total volumes handled, making the company heavily exposed to global trade fluctuations. Any significant disruption in international shipping volumes could adversely impact performance. Market Recap – 23 June On Monday, markets opened sharply lower amid escalating geopolitical tensions stemming from the Iran-Israel conflict and broader global uncertainties. The Nifty 50 index opened at 24,939.75, down 140 points from Friday's close of 25,112.40. The benchmark slipped to an intraday low of 24,824.85 in early trade but staged a partial rebound in the morning session, climbing to a day's high of 25,057 before closing just below the 25,000 mark. Among sectoral performers, the Nifty Media Index led the gains with a surge of 4.39%. Zee Entertainment Enterprises jumped 11.44% after the company announced its plan to achieve breakeven for its streaming platform ZEE5, narrowing EBITDA losses of ₹548 crore in FY25. Network18 Media & Investments Ltd also advanced, rising 3.02%. On the downside, the Nifty IT index declined 1.48%, weighed down by Oracle Financial Services Software, which fell 2.67%, and Infosys Ltd, which declined 2.35%. Also read | Spot freight rates could surge further if Iran shuts Strait of Hormuz Asian markets displayed a mixed trend, while US Dow Jones Futures edged lower, down 0.17% or 71.51 points, to 42,135.31, reflecting investor caution amid the ongoing conflict between Iran and Israel. Trade Brains Portal is a stock analysis platform. Its trade name is Dailyraven Technologies Pvt. Ltd, and its Sebi-registered research analyst registration number is INH000015729. Investments in securities are subject to market risks. Read all the related documents carefully before investing. Registration granted by Sebi and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before making any investment decisions.
